H.C. Wainwright raises Ionis stock price target to $130 on FDA approval
H.C. Wainwright raises Ionis stock price target to $130 on FDA approval
H.C. Wainwright raises Ionis stock price target to $130 on FDA approval
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.